Cyteir Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Cyteir Therapeutics

16/03/2022 20:54

* Cyteir Therapeutics Inc  CYT.OQ  reported a quarterly
adjusted
loss of 34 cents​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was for a
loss of 39 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Cyteir Therapeutics Inc's reported EPS for the quarter was
a
loss of 34 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cyteir Therapeutics Inc shares had fallen by 68.5% this
quarter.
    * The company reported a quarterly loss of $11.82 million.
    * Wall Street's median 12-month price target for Cyteir
Therapeutics Inc is $23.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 16 at 08:54 p.m.  ​All
figures in US dollars unless otherwise stated